journal article·2014-02

Stem cell suspension injected HEMA-lactate-dextran cryogels for regeneration of critical sized bone defects

Nimet Bölgen, Petek Korkusuz, İbrahim Vargel, Emine Kılıç, Elif Güzel, Tarık Çavuşoğlu, Duygu Uçkan, Erhan Pişkin

Publisher page

Abstract

HEMA-Lactate-Dextran cryogel scaffolds were produced by cryogelation. Mesencyhmal stem cells (MSC) were isolated from rat bone marrow. Critical sized cranial bone defects were created in rat cranium. Stem cells were injected inside the macropores of the cryogel scaffolds prepared from HEMA-Lactate-Dextran possessing the same dimensions with the defect and placed in the cranial bone. The cryogels placed in the defect without stem cells served as control. After selected time intervals the experimental sites were removed from the animals and new bone formation and tissue integration were investigated by histological analysis. The in vivo results exhibited osseous tissue integration within the implant and mineralized functionally stable bone restoration of the cranial defects. Tissue formation started in the macrospores of the scaffold starting from periphery to the center. A significant ingrowth of connective tissue cells and new blood vessels allowed new bone formation. Histological data demonstrated that new bone per total defect area ratio, were not significantly different in "scaffold-stem cells" group compared to that of "scaffold only" group on all time points. However, the blood vessel density was significantly higher in "scaffold-stem cells" group comparing to that of the "scaffold only" group on day 30. "Scaffold-stem cells" given group gave better tissue response score when compared to "scaffold only" group on day 180.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Alsberg E · Crit Rev Oral Biol Med · 2001 · 12 · 6410.1177/10454411010120010501 ↗
2. Aronin CEP · J Biomed Mater Res · 2009 · 89 · 63210.1002/jbm.a.32015 ↗
3. Ayatollahi M · World J Stem Cells · 2012 · 26 · 110.4252/wjsc.v4.i1.1 ↗
4. Aydın HM · J Bioact Comp Pol · 2011 · 26 · 20710.1177/0883911511399411 ↗
5. 10.1163/15685620778155406410.1163/156856207781554064 ↗
6. 10.1089/ten.tea.2007.027710.1089/ten.tea.2007.0277 ↗
7. 10.1002/term.37510.1002/term.375 ↗
8. 10.1002/jbm.a.3219310.1002/jbm.a.32193 ↗
9. Caplan AI · Tissue Eng · 2000 · 6 · 110.1089/107632700320838 ↗
10. 10.1163/156856292X0045710.1163/156856292X00457 ↗
11. Godeladze JO · Ilar J · 2009 · 51 · 4210.1093/ilar.51.1.42 ↗
12. 10.1096/fj.07-08792410.1096/fj.07-087924 ↗
13. 10.1163/1568562036067427210.1163/15685620360674272 ↗
14. Hou QP · Biomaterials · 2003 · 24 · 193710.1016/S0142-9612(02)00562-8 ↗
15. Hutmacher D · J Cell Mol Med · 2007 · 11 · 65410.1111/j.1582-4934.2007.00078.x ↗
16. Kim HJ · Biomaterials · 2005 · 26 · 444210.1016/j.biomaterials.2004.11.013 ↗
17. Koc ON · J Clin Oncol · 2000 · 18 · 30710.1200/JCO.2000.18.2.307 ↗
18. Lannutti J · Mater Sci Eng C · 2007 · 27 · 50410.1016/j.msec.2006.05.019 ↗
19. Lazarus HM · Biol Blood Marrow Transplant · 2005 · 33 · 38910.1016/j.bbmt.2005.02.001 ↗
20. Liu X · Ann Biomed Eng · 2004 · 32 · 47710.1023/B:ABME.0000017544.36001.8e ↗
21. Lozinsky V · Bioseparation · 2002 · 10 · 16310.1023/A:1016386902611 ↗
22. Lu M · Int J Oral Maxillofac Surg · 2004 · 33 · 36910.1016/j.ijom.2003.09.009 ↗
23. 10.1634/stemcells.2005-056710.1634/stemcells.2005-0567 ↗
24. Miura M · Oral Dis · 2006 · 12 · 51410.1111/j.1601-0825.2006.01300.x ↗
25. Meinel L · Bone · 2005 · 37 · 68810.1016/j.bone.2005.06.010 ↗
26. Niemeyer P · Tissue Eng Part A · 2010 · 16 · 3310.1089/ten.tea.2009.0190 ↗
27. Quinn CP · Biomaterials · 1995 · 16 · 38910.1016/0142-9612(95)98856-9 ↗
28. Pişkin E · J Biomed Mater Res Part A · 2009 · 90 · 113710.1002/jbm.a.32157 ↗
29. Rockwood DN · Acta Biomater · 2011 · 7 · 14410.1016/j.actbio.2010.07.020 ↗
30. 10.4161/org.604810.4161/org.6048 ↗
31. Sanan A · Neurosurgery · 1997 · 40 · 588
32. Schantz JT · Evaluation of cellular efficiency and efficacy in vivo. Tissue Eng · 2003 · 9 · 127
33. Sharma B · Ann Biomed Eng · 2004 · 32 · 14810.1023/B:ABME.0000007799.60142.78 ↗
34. Srouji S · Tissue Eng Part A · 2011 · 17 · 26910.1089/ten.tea.2010.0250 ↗
35. Weinand C · Bone · 2006 · 38 · 55510.1016/j.bone.2005.10.016 ↗
36. Valero-Cabre´ A · J Neurosci Res · 2001 · 63 · 21410.1002/1097-4547(20010115)63:2<214::AID-JNR1014>3.0.CO;2-D ↗
37. VanDijk-Wolthuis WNE · Biomacromolecules · 1997 · 30 · 463910.1021/ma9704018 ↗
38. Yamada Y · Tissue Eng · 2004 · 10 · 95510.1089/1076327041348284 ↗
39. Zong C · Eur Cell Mater · 2010 · 20 · 10910.22203/eCM.v020a10 ↗